Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Yes, of course in combo, but there is also a high likelihood that while trying to find and clinically prove the best combos, Kevetrin against several cancers will advance as a stand alone. If it stabilizes tumors, eliminates lesions, measurably increases the quality of life, and lengthens life expectancy, they are not going to just sit on their hands until a good combo is approved. If Phase 1 shows efficacy against one or two late-stage cancers, those cancers will be expedited through fast-track clinical trials. Recognize it or not, there are reports of efficacy beyond just increased levels of p21.